JASPER THERAPEUTICS INC
(NASDAQ: JSPR)
Jasper Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in enabling cures through hematopoietic stem cell therapy. It focuses on the development and commercialization of safer, stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside of the body prior to transplantation. The company was founded by Judith Shizuru and Susan Prohaska in March 2018 and is headquartered in Redwood City, CA.
29.640
+0.820
(+2.85%)
Range
29.360 - 31.000
(5.59%)
Open
-
Previous Close
28.820
Bid Price
1.780
Bid Volume
10
Ask Price
1.850
Ask Volume
10
Volume
95,881
Value
-
Remark
View All Events
Loading Chart...
Please login to view stock data and analysis